Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Study shows MM120, a pharmaceutical LSD version, can significantly reduce anxiety for up to 12 weeks.
A study published in the Journal of the American Medical Association shows that a 100 microgram dose of MM120, a pharmaceutical version of LSD, may significantly reduce anxiety symptoms in patients with generalized anxiety disorder for up to 12 weeks.
Most participants experienced mild hallucinations that resolved within 12 hours.
The drugmaker, Mindmed, plans further trials to seek FDA approval, marking a potential shift in the treatment of anxiety disorders with psychedelic drugs.
217 Articles
El estudio muestra que MM120, una versión farmacéutica de LSD, puede reducir significativamente la ansiedad durante hasta 12 semanas.